68Ga-PSMA PET/CT tumour intensity pre-operatively predicts adverse pathological outcomes and progression-free survival in localised prostate cancer (Jul, 10.1007/s00259-020-04944-2, 2020)

Roberts Matthew J.; Morton Andrew; Donato Peter; Kyle Samuel; Pattison David A.; Thomas Paul; Coughlin Geoff; Esler Rachel; Dunglison Nigel; Gardiner Robert A.; Doi Suhail A.; Emmett Louise; Yaxley John

首页> 外文期刊>European Journal of Nuclear Medicine and Molecular Imaging >68Ga-PSMA PET/CT tumour intensity pre-operatively predicts adverse pathological outcomes and progression-free survival in localised prostate cancer (Jul, 10.1007/s00259-020-04944-2, 2020)

【24h】

68Ga-PSMA PET/CT tumour intensity pre-operatively predicts adverse pathological outcomes and progression-free survival in localised prostate cancer (Jul, 10.1007/s00259-020-04944-2, 2020)

机译：68Ga-PSMA PET / CT肿瘤强度预先操作地预测局部前列腺癌（JUL，10.1007 / S00259-020-04944-2,2020）的不良病理结果和无进展生存期）

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Figure 2b is incorrect in the original paper.

机译：None

著录项

来源
《European Journal of Nuclear Medicine and Molecular Imaging》 |2021年第2期|共2页
作者
Roberts Matthew J.; Morton Andrew; Donato Peter; Kyle Samuel; Pattison David A.; Thomas Paul; Coughlin Geoff; Esler Rachel; Dunglison Nigel; Gardiner Robert A.; Doi Suhail A.; Emmett Louise; Yaxley John;
展开▼
作者单位

Royal Brisbane &

Womens Hosp Dept Urol Brisbane Qld Australia;

Univ Queensland Fac Med Brisbane Qld 4006 Australia;

Royal Brisbane &

Womens Hosp Dept Urol Brisbane Qld Australia;

Univ Queensland Fac Med Brisbane Qld 4006 Australia;

Univ Queensland Fac Med Brisbane Qld 4006 Australia;

Univ Queensland Fac Med Brisbane Qld 4006 Australia;

Royal Brisbane &

Womens Hosp Dept Urol Brisbane Qld Australia;

Royal Brisbane &

Womens Hosp Dept Urol Brisbane Qld Australia;

Royal Brisbane &

Womens Hosp Dept Urol Brisbane Qld Australia;

Royal Brisbane &

Womens Hosp Dept Urol Brisbane Qld Australia;

Qatar Univ Dept Populat Med Coll Med QU Hlth Doha Qatar;

St Vincents Hosp Dept Theranost &

Nucl Med Sydney NSW Australia;

Royal Brisbane &

Womens Hosp Dept Urol Brisbane Qld Australia;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类放射医学;
关键词

相似文献

外文文献
中文文献

1. Prostate-specific antigen half-life: a new predictor of progression-free survival and overall survival in Chinese prostate cancer patients [J] . Guo-Wen Lin, Guo-Hai Shi, Xiao-Jian Qin, 亚洲男性学杂志（英文版） . 2009,第004期
2. A 18FDG PET/CT-based volume parameter is a predictor of overall survival in patients with local advanced gastric cancer [J] . Jinling Song, Zhongwu Li, Puyun Chen, 中国癌症研究（英文版） . 2019,第004期
3. Ga-68-PSMA PET/CT tumour intensity pre-operatively predicts adverse pathological outcomes and progression-free survival in localised prostate cancer [J] . Roberts Matthew J., Morton Andrew, Donato Peter, European Journal of Nuclear Medicine and Molecular Imaging . 2021,第2期

机译：GA-68-PSMA PET / CT肿瘤强度预先可操作地预测局部前列腺癌的不利病理结果和无进展生存率
4. Prostate Cancer Antigen 3 Score Does Not Predict for Adverse Pathologic Features at Radical Prostatectomy or for Progression-free Survival in Clinically Localized, Intermediate- and High-risk Prostate Cancer [J] . John V. Hegde, Darlene Veruttipong, Jonathan W. Said, Urology . 2017,第期

机译：前列腺癌抗原3得分不会预测基底前列腺切除术或在临床局部，中间和高风险前列腺癌中的无进展生存期的不良病理特征
5. Progression-free and overall survival in metastatic castration-resistant prostate cancer treated with abiraterone acetate can be predicted with serial C11-acetate PET/CT [J] . Farnebo Jacob, Wadelius Agnes, Sandstrom Per, Medicine. . 2016,第31期

机译：可以使用连续的C11-醋酸酯PET / CT预测使用醋酸阿比特龙治疗的转移性去势抵抗性前列腺癌的无进展生存期和总生存期
6. Progression-free and overall survival in metastatic castration-resistant prostate cancer treated with abiraterone acetate can be predicted with serial C11-acetate PET/CT [O] . Jacob Farnebo, Agnes Wadelius, Per Sandström, -1

机译：可以通过连续的C11-醋酸酯PET / CT预测使用醋酸阿比特龙治疗的转移性去势抵抗性前列腺癌的无进展生存期和总生存期
7. Correction to: 68Ga-PSMA PET/CT tumour intensity pre-operatively predicts adverse pathological outcomes and progression-free survival in localised prostate cancer [O] . Matthew J. Roberts, Andrew Morton, Peter Donato, 2020

机译：校正至：68Ga-PSMA PET / CT肿瘤强度预先操作地预测局部前列腺癌中的不良病理结果和无进展生存率

68Ga-PSMA PET/CT tumour intensity pre-operatively predicts adverse pathological outcomes and progression-free survival in localised prostate cancer (Jul, 10.1007/s00259-020-04944-2, 2020)

摘要

著录项

相似文献

相关主题

期刊订阅